Table 5. Previous chemotherapy (paraprotein type and response to “DD Protocol”) of 11 patients with stage III multiple myeloma.
Number of patients | Previous chemotherapy courses | Paraprotein type and response to DD Protocol |
---|---|---|
1 | 12 MP + 1 VBMCP | IgG – CR |
1 | 12 MP + LPCV | IgA – PR |
1 | 13 MP | IgG – PD |
1 | 8 MP | IgA – CR |
1 | 12 MP + 3 VAD | IgG – PD |
1 | MP | IgG – CR |
3 | MP + VBMCP + VAD | IgG – 2 CR, 1 MR |
2 | None | IgG – CR, PR |
M = melphalan, P = prednisone, V = vincristine, B = bleomycin, C = cyclophosphamide, A = adriamycin, D = dexamethasone, L = L-asparaginase, IgG = myeloma immunoglobulin G type, IgA = myeloma immunoglobulin A type, λ = myeloma lambda type, κ = myeloma kappa type, PR = partial response, CR = complete response, PD = progressive disease, MR = minimal response).